BRD2 and non-functioning pituitary adenoma: These exciting findings help ones to in-depth understand molecular characteristics, especially its invasiveness-related molecular characteristics of FSH-positive NFPAs, which exactly helps one to resolve the challenging clinical problem—invasiveness and aggressiveness in NFPA patients.